CCL2 and glomerulosclerosis: Accordingly, in an animal model of nephrectomy in db/db mice, increased H3K4me2 renal levels were associated with renal function loss and glomerulosclerosis, and this effect was diminished by treatment with MCP-1/CCL2 antagonist (Spiegelmer mNOX-E36) [120].